Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Characterizing cell-type-specific contributions of a high-penetrance gene for autism spectrum disorder: Implications for brain and behavioural development
EF 2024-25
Résumé
The global prevalence of autism spectrum disorder (ASD) has increased by 243% since 2000. ASD is characterized by deficits in social interaction, communication, and repetitive behaviours. The gene most strongly associated with ASD is CHD8 (Chd8 in non-primates), which encodes for chromodomain-helicase-DNA-binding protein 8. About 85% of individuals with CHD8 mutations present with ASD-related behavioural deficits and macrocephaly. Animal models using global Chd8 knockdown have recapitulated these phenotypes and implicated increases in the number of either neurons or oligodendrocytes in these outcomes. However, global Chd8 suppression lacks the cellular resolution necessary to understand cell-type-specific contributions to Chd8-associated ASD. Carried out at the Lurie Center for Autism at the Massachusetts General Hospital, I propose a program that will provide a preclinical understanding of the roles of neurons, oligodendrocytes, microglia, and astrocytes in the predominant outcomes of Chd8 mutation: ASD-like behavioural deficits and macrocephaly. This exploration is critical as it will provide the first cellular insights into the pathogenesis of CHD8-associated ASD. We will achieve this by leveraging well-established genetic techniques to create novel cell-type-specific mouse lines. First, I will validate and perform a behavioural battery at critical periods to comprehensively understand the contributions of each cell type on ASD-relevant behaviours. Second, I will assess contributions to brain volumetric enlargement using one of North America's most advanced magnetic resonance imaging murine scanner to study whole-brain and region-specific macrocephaly, ending with a quantification of cell numbers in critical regions using histological analyses. This innovative research will guide future molecular, functional, and post-mortem experiments, as well as human neuroimaging studies to ultimately usher in therapeutic strategies for CHD8-linked ASD and related conditions.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
511896
Name
Bishnoi Indra R
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Characterizing cell-type-specific contributions of a high-penetrance gene for autism spectrum disorder: Implications for brain and behavioural development
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Autism Spectrum Disorder (Asd); Behavioural Battery; Chromodomain-Helicase-Dna-Binding Protein 8; Ex Vivo Magnetic Resonance Imaging; Glia; Histology; Macrocephaly; Neurodevelopmental Disorders (Ndd); Neurons; Sex Differences
Abstract
The global prevalence of autism spectrum disorder (ASD) has increased by 243% since 2000. ASD is characterized by deficits in social interaction, communication, and repetitive behaviours. The gene most strongly associated with ASD is CHD8 (Chd8 in non-primates), which encodes for chromodomain-helicase-DNA-binding protein 8. About 85% of individuals with CHD8 mutations present with ASD-related behavioural deficits and macrocephaly. Animal models using global Chd8 knockdown have recapitulated these phenotypes and implicated increases in the number of either neurons or oligodendrocytes in these outcomes. However, global Chd8 suppression lacks the cellular resolution necessary to understand cell-type-specific contributions to Chd8-associated ASD. Carried out at the Lurie Center for Autism at the Massachusetts General Hospital, I propose a program that will provide a preclinical understanding of the roles of neurons, oligodendrocytes, microglia, and astrocytes in the predominant outcomes of Chd8 mutation: ASD-like behavioural deficits and macrocephaly. This exploration is critical as it will provide the first cellular insights into the pathogenesis of CHD8-associated ASD. We will achieve this by leveraging well-established genetic techniques to create novel cell-type-specific mouse lines. First, I will validate and perform a behavioural battery at critical periods to comprehensively understand the contributions of each cell type on ASD-relevant behaviours. Second, I will assess contributions to brain volumetric enlargement using one of North America's most advanced magnetic resonance imaging murine scanner to study whole-brain and region-specific macrocephaly, ending with a quantification of cell numbers in critical regions using histological analyses. This innovative research will guide future molecular, functional, and post-mortem experiments, as well as human neuroimaging studies to ultimately usher in therapeutic strategies for CHD8-linked ASD and related conditions.
Competitiondate
202409
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Bishnoi, Indra R
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~